Analytical reference standards · Impurity / metabolite / stable-isotope products · Worldwide shipping
Quotation within 1 business day · sales@aurstandards.com
Request quotation
Home/Products/ Antiinfectives for systemic use/Dolutegravir

Dolutegravir reference standards

90 products 87 with structure published ATC J05AJ03 Parent API approved (FDA / EMA)
90Reference standards
87With structure published
JAntiinfectives for systemic use
J05AJ03ATC code

All Dolutegravir reference standards

CatalogueCompoundCASClass
D0011-0015Dolutegravir Sodium Impurity 5 Monomer1309560-49-3Impurity
D0011-0016Dolutegravir Impurity 61809261-48-0Impurity
D0011-0017Dolutegravir Sodium Impurity 61357289-29-2Impurity
D0011-0022Dolutegravir Sodium Impurity 91485692-21-4Impurity
D0011-0024Dolutegravir Sodium Impurity 101485081-26-2Impurity
D0011-0026Dolutegravir Sodium Impurity 111246616-78-3Impurity
D0011-0028Dolutegravir Sodium Impurity 121206102-11-5Impurity
D0011-0030Dolutegravir Sodium Impurity 131863916-88-4Impurity
D0011-0032Dolutegravir Sodium Impurity 141335210-23-5Impurity
D0011-0034Dolutegravir Sodium Impurity 152244161-71-3Impurity
D0011-0035Dolutegravir Sodium Impurity 161822365-49-0Impurity
D0011-0037Dolutegravir Sodium Impurity 171802141-49-6Impurity
D0011-0038(S)-Dolutegravir Impurity 182512216-43-0Impurity
D0011-0040Dolutegravir Sodium Impurity 182730133-58-9Impurity
D0011-0042Dolutegravir Sodium Impurity 191246616-73-8Impurity
D0011-0044Dolutegravir Sodium Impurity 202227442-13-7Impurity
D0011-0046Dolutegravir Sodium Impurity 212244161-74-6Impurity
D0011-0048Dolutegravir Sodium Impurity 222384108-28-3Impurity
D0011-0050Dolutegravir Sodium Impurity 232710626-41-6Impurity
D0011-0054Dolutegravir Sodium Impurity 252315439-81-5Impurity
D0011-0077Dolutegravir Sodium Impurity 5241051-15-4Impurity
D0011-0121Dolutegravir M31485692-24-7Related substance
D0011-0125Dolutegravir-d52249814-82-0Stable-isotope labelled analogue
D0011-0126Dolutegravir D61407167-38-7Stable-isotope labelled analogue
D0011-0131(4R,12aS)-N-((2,4-difluorophenyl-3-d)methyl-d2)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1&#x272673270-25-0Stable-isotope labelled analogue
D0011-0153(2,4-Difluorobenzyl)carbamic acid1897709-05-5Related substance
D0011-0155(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide1051375-16-6Related substance
D0011-0156(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-methoxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide1335210-35-9Related substance
D0011-0161(4R,12aS)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid1623085-80-2Related substance
D0011-0165(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid1335210-34-8Related substance
D0011-0166(4R,12aS)-N-((2,4-difluorophenyl)methyl-d2)-7-hydroxy-4-(methyl-d3)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-4-d-9-carboxamide1407166-95-3Stable-isotope labelled analogue
D0011-0176(4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2244161-72-4Related substance
D0011-0177(4R,12aS)-N-(2,6-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2244245-35-8Related substance
D0011-0179(4R,12aS)-N-(2-fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide1863916-87-3Related substance
D0011-0180(4R,12aS)-N-(2-fluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2244245-36-9Related substance
D0011-0181(4R,12aS)-N-(4-fluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2244245-33-6Related substance
D0011-0182(4R,12aS)-N-(5-benzyl-2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide1973402-10-6Related substance
D0011-0184(4R,12aS)-N-[(4-Fluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1`,2`:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide sodium salt3093141-60-4Salt / salt form
D0011-0186(4R,12aS)-N-benzyl-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2244245-34-7Related substance
D0011-0187(4R,9aS)-4-methyltetrahydro-2H,6H-pyrazino[2,1-b][1,3]oxazine-6,9(9aH)-dione1800247-08-8Related substance
D0011-0190(4S,12aR)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid2583719-60-0Related substance
D0011-0191(4S,12aR)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2583719-57-5Related substance
D0011-0193(4S,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide1357289-37-2Related substance
D0011-0195(4S,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide & (4R,12aR)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide2968897-85-8Related substance
D0011-0198(R)-3-(7-((2,4-difluorobenzyl)carbamoyl)-9-hydroxy-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazin-2-yl)butyl (2,4-difluorobenzyl)carbamate2244161-73-5Related substance
D0011-0201(R)-3-(ethylamino)butan-1-ol136744-92-8Related substance
D0011-0202(R)-3-(methylamino)butan-1-ol1620680-35-4Related substance
D0011-0203(R)-3-aminobutanoic acid3775-73-3Related substance
D0011-0208(R)-9-Hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxylic Acid3028615-32-6Related substance
D0011-0209(R)-ETHYL-3-ACETAMIDOBUTYRATE187989-67-9Related substance
D0011-0211(R)-N-(2,4-difluorobenzyl)-9-ethoxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide3093141-58-0Related substance
D0011-0212(R)-N-(2,4-difluorobenzyl)-9-ethoxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide2778347-47-8Related substance
D0011-0213(R)-N-(2,4-difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide2518311-04-9Related substance
D0011-0214(R)-N-(2,4-difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide1973402-05-9Related substance
D0011-0224(S)-N-(2,4-difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide2731934-64-6Related substance
D0011-0226(Z)-methyl-4-(benzyloxy)-2-((dimethylamino)methylene)-3-oxobutanoate1246616-65-8Related substance
D0011-02311-[(2,4-Difluorophenyl)acetyl]-1H-imidazole603999-55-9Related substance
D0011-02342,4-difluorobenzonitrile3939-09-1Related substance
D0011-02352,5-Difluoro Dolutegravir30-15-9Related substance
D0011-02372-(3,4-difluorophenyl)propan-1-amine1096790-45-2Related substance
D0011-02382-[(1E)-2-Phenylethenyl]-3-(phenylmethoxy)-4H-pyran-4-one1206102-05-7Related substance
D0011-02402H-Pyrido[1,2-a]pyrazine-7-carboxamide, N-[(2,4-difluorophenyl)methyl]-1,8-dihydro-9-hydroxy-2-[(1R)-3-hydroxy-1-methylpropyl]-1,8-dioxo-, Sodium Salt (1:1)2769753-77-5Salt / salt form
D0011-02422H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-1830380-29-4Related substance
D0011-02432H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[[4-[[(2,4-difluorophenyl)methyl]amino]-2-fluorophenyl]methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-, (4R,12aS)2767197-74-8Related substance
D0011-02453-(Benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylic acid1206102-06-8Related substance
D0011-02463-(methylamino)butan-1-ol2704-55-4Related substance
D0011-02473-Aminobutan-1-ol2867-59-6Related substance
D0011-02535-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dihydroxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid2940947-95-3Related substance
D0011-02585-((2,4-difluorobenzyl)carbamoyl)-3-methoxy-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylic acid2384108-26-1Related substance
D0011-02595-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-1,4-dihydro-3-hydroxy-4-oxo-1-[(tetrahydro-4-methyl-2H-1,3-oxazin-2-yl)methyl]-2-pyridinecarboxylic Acid1800247-07-7Related substance
D0011-02635-methoxy-6-(methoxycarbonyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-3-carboxylic acid1335210-31-5Related substance
D0011-0268dimethyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate1646862-02-3Related substance
D0011-0270Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate1246616-66-9Related substance
D0011-0273Dolutegravir 3-Hydroxy Impurity1309562-96-6Impurity
D0011-0278Dolutegravir ethyl ester impuirty2677842-37-2Related substance
D0011-0284Dolutegravir Sodium Monohydrate-API Standards1229006-39-6Salt / salt form
D0011-0287methyl (4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate2958649-37-9Related substance
D0011-0289methyl (E)-2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate1646862-12-5Related substance
D0011-0291methyl (Z)-2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate1646862-18-1Related substance
D0011-0292methyl (Z)-2-((dimethylamino)methylene)-4-methoxy-3-oxobutanoate1191097-60-5Related substance
D0011-0294Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate1206102-07-9Related substance
D0011-0295methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylate1229006-25-0Related substance
D0011-0298methyl 5-((2,4-difluorobenzyl)carbamoyl)-3-methoxy-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylate1646862-09-0Related substance
D0011-0299N,N-DIMETHYLAMINOMETHYLENEMALONIC ACID DIMETHYL ESTER18856-69-4Related substance
D0011-0303N-(2,4-difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide2374716-73-9Related substance
D0011-0305N-(2,4-difluorobenzyl)acetimidamide1341434-11-4Related substance
D0011-0306N-[(2,4-Difluorophenyl)methylene]-2,4-difluoro-benzenemethanamine1916490-96-4Related substance
D0011-0309sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate1051375-19-9Salt / salt form
D0011-0314sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate1309575-43-6Salt / salt form
D0011-0321Dolutegravir Impurity 45127958-23-0Impurity